Works about DIMETHYL fumarate

Results: 398
    1
    2
    3
    4
    5
    6

    Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used.

    Published in:
    GeroScience, 2024, v. 46, n. 1, p. 795, doi. 10.1007/s11357-023-01011-0
    By:
    • Harrison, David E.;
    • Strong, Randy;
    • Reifsnyder, Peter;
    • Rosenthal, Nadia;
    • Korstanje, Ron;
    • Fernandez, Elizabeth;
    • Flurkey, Kevin;
    • Ginsburg, Brett C.;
    • Murrell, Meredith D.;
    • Javors, Martin A.;
    • Lopez-Cruzan, Marisa;
    • Nelson, James F.;
    • Willcox, Bradley J.;
    • Allsopp, Richard;
    • Watumull, David M.;
    • Watumull, David G.;
    • Cortopassi, Gino;
    • Kirkland, James L.;
    • Tchkonia, Tamar;
    • Choi, Young Geun
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39174-1
    By:
    • Ryan, Tristram A. J.;
    • Hooftman, Alexander;
    • Rehill, Aisling M.;
    • Johansen, Matt D.;
    • Brien, Eóin C. O';
    • Toller-Kawahisa, Juliana E.;
    • Wilk, Mieszko M.;
    • Day, Emily A.;
    • Weiss, Hauke J.;
    • Sarvari, Pourya;
    • Vozza, Emilio G.;
    • Schramm, Fabian;
    • Peace, Christian G.;
    • Zotta, Alessia;
    • Miemczyk, Stefan;
    • Nalkurthi, Christina;
    • Hansbro, Nicole G.;
    • McManus, Gavin;
    • O'Doherty, Laura;
    • Gargan, Siobhan
    Publication type:
    Article
    18

    Publisher Correction: Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon.

    Published in:
    2023
    By:
    • Ryan, Tristram A. J.;
    • Hooftman, Alexander;
    • Rehill, Aisling M.;
    • Johansen, Matt D.;
    • O' Brien, Eóin C.;
    • Toller-Kawahisa, Juliana E.;
    • Wilk, Mieszko M.;
    • Day, Emily A.;
    • Weiss, Hauke J.;
    • Sarvari, Pourya;
    • Vozza, Emilio G.;
    • Schramm, Fabian;
    • Peace, Christian G.;
    • Zotta, Alessia;
    • Miemczyk, Stefan;
    • Nalkurthi, Christina;
    • Hansbro, Nicole G.;
    • McManus, Gavin;
    • O'Doherty, Laura;
    • Gargan, Siobhan
    Publication type:
    Correction Notice
    19

    Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon.

    Published in:
    Nature Communications, 2023, n. 1, p. 1, doi. 10.1038/s41467-023-39174-1
    By:
    • Ryan, Tristram A. J.;
    • Hooftman, Alexander;
    • Rehill, Aisling M.;
    • Johansen, Matt D.;
    • Brien, Eóin C. O';
    • Toller-Kawahisa, Juliana E.;
    • Wilk, Mieszko M.;
    • Day, Emily A.;
    • Weiss, Hauke J.;
    • Sarvari, Pourya;
    • Vozza, Emilio G.;
    • Schramm, Fabian;
    • Peace, Christian G.;
    • Zotta, Alessia;
    • Miemczyk, Stefan;
    • Nalkurthi, Christina;
    • Hansbro, Nicole G.;
    • McManus, Gavin;
    • O'Doherty, Laura;
    • Gargan, Siobhan
    Publication type:
    Article
    20

    Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39174-1
    By:
    • Ryan, Tristram A. J.;
    • Hooftman, Alexander;
    • Rehill, Aisling M.;
    • Johansen, Matt D.;
    • Brien, Eóin C. O';
    • Toller-Kawahisa, Juliana E.;
    • Wilk, Mieszko M.;
    • Day, Emily A.;
    • Weiss, Hauke J.;
    • Sarvari, Pourya;
    • Vozza, Emilio G.;
    • Schramm, Fabian;
    • Peace, Christian G.;
    • Zotta, Alessia;
    • Miemczyk, Stefan;
    • Nalkurthi, Christina;
    • Hansbro, Nicole G.;
    • McManus, Gavin;
    • O'Doherty, Laura;
    • Gargan, Siobhan
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome.

    Published in:
    Annals of Neurology, 2023, v. 93, n. 3, p. 604, doi. 10.1002/ana.26555
    By:
    • Okuda, Darin T.;
    • Kantarci, Orhun;
    • Lebrun‐Frénay, Christine;
    • Sormani, Maria Pia;
    • Azevedo, Christina J.;
    • Bovis, Francesca;
    • Hua, Le H.;
    • Amezcua, Lilyana;
    • Mowry, Ellen M.;
    • Hotermans, Christophe;
    • Mendoza, Jason;
    • Walsh, John S.;
    • von Hehn, Christian;
    • Vargas, Wendy S.;
    • Donlon, Stacy;
    • Naismith, Robert T.;
    • Okai, Annette;
    • Pardo, Gabriel;
    • Repovic, Pavle;
    • Stüve, Olaf
    Publication type:
    Article
    28

    Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia.

    Published in:
    Annals of Neurology, 2022, v. 91, n. 5, p. 676, doi. 10.1002/ana.26328
    By:
    • Diebold, Martin;
    • Galli, Edoardo;
    • Kopf, Andreas;
    • Sanderson, Nicholas;
    • Callegari, Ilaria;
    • Ingelfinger, Florian;
    • Núñez, Nicolás Gonzalo;
    • Benkert, Pascal;
    • Kappos, Ludwig;
    • Kuhle, Jens;
    • Becher, Burkhard;
    • Claassen, Manfred;
    • Derfuss, Tobias
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36

    A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles.

    Published in:
    Molecules, 2021, v. 26, n. 4, p. 1085, doi. 10.3390/molecules26041085
    By:
    • García-Fernández, Francisco Javier;
    • García-Fernández, Alba Estela;
    • Ikuta, Ichiro;
    • Nava, Eduardo;
    • Solis García del Pozo, Julian;
    • Jordan, Joaquin;
    • Galindo, Maria F.;
    • Curulli, Antonella;
    • Aprea, Eugenio;
    • Cardona, Francesca;
    • Chinou, Ioanna;
    • Gauld, James;
    • Kotra, Lakshmi;
    • Peruzzini, Maurizio
    Publication type:
    Article
    37
    38
    39
    40
    41

    Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1).

    Published in:
    Dermatology & Therapy, 2023, v. 13, n. 1, p. 329, doi. 10.1007/s13555-022-00863-2
    By:
    • Daudén, Esteban;
    • de la Cueva, Pablo;
    • Salgado-Boquete, Laura;
    • Llamas-Velasco, Mar;
    • Fonseca, Eduardo;
    • Pau-Charles, Ignasi;
    • Asensio, David;
    • Guilà, Meritxell;
    • Carrascosa, José Manuel;
    • DIMESKIN 1 Study investigators;
    • Linares, Mario;
    • Vélez, Antonio;
    • Yébenes, Mireia;
    • Mollet, Jordi;
    • Gardeazabal, Jesús;
    • Flórez, Ángeles;
    • Suárez, José;
    • Armesto, Susana;
    • Fernández, Almudena;
    • Ruiz, José Carlos
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88624-7
    By:
    • Walo-Delgado, Paulette Esperanza;
    • Sainz de la Maza, Susana;
    • Villarrubia, Noelia;
    • Monreal, Enric;
    • Medina, Silvia;
    • Espiño, Mercedes;
    • Fernández-Velasco, José Ignacio;
    • Rodríguez-Martín, Eulalia;
    • Roldán, Ernesto;
    • Lourido, Daniel;
    • Muriel, Alfonso;
    • Masjuan-Vallejo, Jaime;
    • Costa-Frossard, Lucienne;
    • Villar, Luisa María
    Publication type:
    Article
    48
    49
    50